Altamira Therapeutics Ltd - Warrants (29/03/2028) Other Current Liabilities

As of the most recent data (December 2024), CYTOW shows a other current liabilities of $520K. That compares with $380K in the prior-year period — up 37.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYTOW's other current liabilities is now $520K (was $380K) — a 37.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Altamira Therapeutics Ltd - Warrants (29/03/2028) is outperforming or lagging.

Tracking CYTOW's other current liabilities over time shows whether Altamira Therapeutics Ltd - Warrants (29/03/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $520K That compares with $380K in the prior-year period — up 37.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Altamira Therapeutics Ltd - Warrants (29/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $520K) with ownership activity and broader fundamentals.

Altamira Therapeutics Ltd - Warrants (29/03/2028)'s other current liabilities is $520K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.